Products
Online Inquiry
Namodenoson
Cat. No.:
0225LY-0643
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Namodenoson functions as a specific agonist for the adenosine A3 receptor.
Synonym:
163042-96-4; Namodenoson; (2S,3S,4R,5R)-5-(2-Chloro-6-((3-iodobenzyl)amino)-9H-purin-9-yl)-3,4-dihydroxy-N-methyltetrahydrofuran-2-carboxamide; (2S,3S,4R,5R)-5-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyloxolane-2-carboxamide; 2-Chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide; Beta-D-Ribofuranuronamide, 1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-
CAS No.:
163042-96-4
Compound CID:
3035850
Formula:
C18H18ClIN6O4
Formula Weight:
544.73
Specification
Targets&IC50:
A3 receptor: 0.33 nM (Ki)
Relative Density:
2.04 g/cm3 at 20°C.
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Namodenoson can be used in hepatology research to examine its role as a selective A3 adenosine receptor agonist.
Library Information
Target:
Adenosine receptor
Receptor:
A3
Pathways:
GPCR/G protein signaling; Neuronal signaling
Plate Number:
AOCL-9
Plate Location:
c9
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
31 mg/mL; 56.91 mM
